Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Bullboard Posts
Comment by zoomzoom3on Jul 17, 2014 9:30pm
248 Views
Post# 22757695

RE:question for early campers

RE:question for early campers
Now is a great time to enter IMHO. ICO released some data on their iCo-007 drug and it failed to meet expectations but ICO figures they had a hard to treat set of people which may have caused the results. They are waiting to get farther data on the patients involved to see what they cant find and hopefully find a sub-group as some did respond to the treatment. They are also awaiting results on the iCo-008 (1-3 weeks out) and have iCo-009. They also have 8 cents per share in cash in the bank from a 42 cent private placement earlier in the year as well as an investment in Immune Pharma which is worth probably another 3 cents per share. Zack's research has a today value on ICO of 15 cents per share U.S.$ which is over 100% from where we closed today. Stock has been oversold but people are starting to see there is lots of value here hence the big volume buying lately. Oh, almost forgot to mention that the top two guys for ICO have recently bought more shares in the open market to add to their already large positions. Management own a lot of shares and heavily invested so they will do everything possible to make ICO a success. This about wraps it up CB and I invite any others on the board to add some content that I may have left out. The chart is turning Bullish and there is a big gap to be filled sometime into the future all the way up to 31 Cents. Will it get there???? Hope so some day :) GLTA
Bullboard Posts